Arovella Therapeutics Limited (AU:ALA) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Arovella Therapeutics Limited reported a significant decline in revenues, down 98.8% to $17,000, with a decreased annual loss of 14.1% amounting to $(8,746,035). Despite the reduced losses, the company did not pay or declare dividends for the financial year ending June 30, 2024, maintaining a net tangible asset increase per security from 0.44 to 1.07 cents.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.